A UCLA-led study found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, do not necessarily improve a patient’s long-term overall survival.
Tag: PSA
Study Finds Providers Use Prostate Cancer Screening Tests, Even When They Provide Little Value to Patients
Prostate cancer is the second-leading cause of cancer death in men with more than 34,000 deaths in the U.S. each year, according to the American Cancer Society. But guidelines for prostate cancer screening are continually shifting, leading to uncertainty among patients and providers on when and if screening tests should be ordered. In a new study from Wake Forest University School of Medicine, researchers recently examined prostate screening testing among primary care providers and found that the tests are frequently used, even when they provide little value to patients.
Improve recycling compliance by using this technique in PSAs
A specific messaging strategy used in a public service announcement (PSA) video can effectively encourage New Yorkers who struggle with recycling compliance to properly separate their trash from recycling, according to the results of a University at Buffalo study.
Infection Rates in Psoriatic Arthritis Patients on Biologics Have Decreased, According to National Data
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows significant decreases in infections among people with psoriatic arthritis over the years 2012-2017.
Study: New Prostate Cancer Test Could Avoid Unnecessary Biopsies
A urine test based on University of Michigan Rogel Cancer Center research could have avoided one third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study that included more than 1,500 patients.